<code id='5F9A06C5D8'></code><style id='5F9A06C5D8'></style>
    • <acronym id='5F9A06C5D8'></acronym>
      <center id='5F9A06C5D8'><center id='5F9A06C5D8'><tfoot id='5F9A06C5D8'></tfoot></center><abbr id='5F9A06C5D8'><dir id='5F9A06C5D8'><tfoot id='5F9A06C5D8'></tfoot><noframes id='5F9A06C5D8'>

    • <optgroup id='5F9A06C5D8'><strike id='5F9A06C5D8'><sup id='5F9A06C5D8'></sup></strike><code id='5F9A06C5D8'></code></optgroup>
        1. <b id='5F9A06C5D8'><label id='5F9A06C5D8'><select id='5F9A06C5D8'><dt id='5F9A06C5D8'><span id='5F9A06C5D8'></span></dt></select></label></b><u id='5F9A06C5D8'></u>
          <i id='5F9A06C5D8'><strike id='5F9A06C5D8'><tt id='5F9A06C5D8'><pre id='5F9A06C5D8'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:33146
          Powdered ibogaine against a white background.
          Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

          The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

          The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

          advertisement

          But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Sage's campaign to raise awareness of postpartum depression hits a nerve
          Sage's campaign to raise awareness of postpartum depression hits a nerve

          Thecampaignfeatureswomenwithpacifiersintheirmouthsandtheslogan"SilenceSucks."SageTherapeuticsSageThe

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          With FDA staff opposed to Sarepta therapy, top official intervened

          AlogosignoutsideoftheheadquartersofSareptaTherapeuticsinCambridge,Mass.KristofferTripplaar/SipaviaAP